Abstract
New arylpiperazines with a four-methylene spacer containing a terminal pyrimido[2,1-f] theophylline fragment were synthesized, and their 5-HT1A and 5-HT2A receptor affinities were determined. All these compounds displayed a high affinity for 5-HT1A receptors (Ki=0.5-21.5 nM), and low affinity for 5-HT2A ones. The results of in vivo experiments showed that compounds revealed potential agonistic activity at presynaptic 5-HT1A receptors, whereas their functional activity at postsynaptic 5-HT1A sites was diversified. In fact, compounds and behaved like partial agonists, antagonists or agonists of postsynaptic 5-HT1A receptors, respectively. The pharmacological properties of the tested compounds were discussed in comparison with those of the three methylene-analogs described earlier.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Behavior, Animal / drug effects
-
Binding, Competitive
-
Body Temperature / drug effects
-
Cerebral Cortex / metabolism
-
Hippocampus / metabolism
-
Ligands
-
Male
-
Mice
-
Piperazines / chemical synthesis*
-
Piperazines / chemistry
-
Piperazines / pharmacology
-
Radioligand Assay
-
Rats
-
Rats, Wistar
-
Receptor, Serotonin, 5-HT1A / metabolism*
-
Receptor, Serotonin, 5-HT2A / metabolism*
-
Serotonin Agents / chemical synthesis*
-
Serotonin Agents / chemistry
-
Serotonin Agents / pharmacology
-
Structure-Activity Relationship
-
Theophylline / analogs & derivatives*
-
Theophylline / chemical synthesis*
-
Theophylline / chemistry
-
Theophylline / pharmacology
Substances
-
Ligands
-
Piperazines
-
Receptor, Serotonin, 5-HT2A
-
Serotonin Agents
-
Receptor, Serotonin, 5-HT1A
-
Theophylline